Skip to main content

Table 9 Demographics and organ involvement characteristics of various cohorts

From: Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts

Characteristics

UMN

(n = 187)

ACCESS

(n = 736)

Israel (n = 166)

Mexico City

(n = 21)

UCSF

(n = 126)

Olmsted County (n = NA)

Mean age ± SD (years)

45.8 ± 12.4a

(46% < 40 yr old, 54% ≥ 40 yr old)a

62 ± 14

NA

50 ± 12b

NA

Median age (years)

45 (22–75)a

42.1 (18–83)a

63 (26–94)

31 (18–72)a

51 (30–76)b

NA

Male, n (%)

103 (55.1)

268 (36.4)

54 (32.5)

10 (47.6)

49 (39)

NA

Female, n (%)

84 (44.9)

468 (63.6)

112 (67.5)

11 (52.4)

77 (61)

NA

White, n (%)

132 (70.6)

393 (53.4)

NA

NA

97 (77)

NA

Black, n (%)

32 (17.1)

325 (44.2)

NA

NA

18 (14)

NA

Other, n (%)

23 (12.3)

18 (2.4)

Jew: 111 (67)

Arab: 51 (31)

Ethiopian 4 (2)

NA

11 (9)

NA

Lungs, n (%)

184 (98.4)

699 (95.0)

151 (91.0)

14 (66.6)

NA

97%

Skinc, n (%)

27 (14.4)

178 (24.2)

5 (3.0)

9 (42.8)

NA

18%

Non-thoracic lymph node, n (%)

64 (34.2)

112 (15.2)

5 (3.0)

4 (19.0)

NA

3%

Eye, n (%)

39 (20.9)

87 (11.8)

6 (3.6)

4 (19.0)

NA

7%

Liver, n (%)

33 (17.6)

85 (11.5)

6 (3.6)

4 (19)

NA

6%

Spleen, n (%)

39 (20.9)

49 (6.7)

6 (3.6)

0 (0.0)

NA

4%

Neurologic, n (%)

14 (7.5)

34 (4.6)

12 (7.2)

0 (0.0)

23 (18.3%)

3%

Parotid/salivary, n (%)

4 (2.1)

29 (3.9)

0 (0.0)

1 (4.7)

NA

NA

Bone marrow, n (%)

6 (3.2)

29 (3.9)

1 (0.6)

5 (23.8)

NA

NA

Calcium, n (%)

10 (5.3)

27 (3.7)

1 (0.6)

1 (4.7)

NA

NA

ENT, n (%)

4 (2.1)

22 (3.0)

0 (0.0)

1 (4.7)

NA

NA

Cardiac, n (%)

20 (10.7)

17 (2.3)

1 (0.6)

0 (0.0)

5 (4.0%)

1%

Renal, n (%)

2 (1.1)

5 (0.7)

4 (2.4)

0 (0.0)

NA

3%

Bone/joint, n (%)

18 (9.6)

4 (0.5)

6 (3.6)

0 (0.0)

NA

12%

Muscle, n (%)

2 (1.1)

3 (0.4)

0 (0.0)

0 (0.0)

NA

NA

  1. ENT ear, nose, and throat, UMN University of Minnesota, ACCESS A Case Control Etiologic Study of Sarcoidosis, UCSF University of California San Francisco
  2. aAge at diagnosis
  3. bAge at visit
  4. cIncluding erythema nodosum